Apeloa Pharmaceutical Co Ltd (000739) — Free Cash Flow Generation Index
Apeloa Pharmaceutical Co Ltd (000739) has a Free Cash Flow Generation Index of 0.63x as of December 2025. Free cash flow of CN¥279.45 Million represents 1% of operating cash flow (CN¥446.18 Million). Read Apeloa Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Apeloa Pharmaceutical Co Ltd across 26 annual periods. Explore 000739 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Apeloa Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Apeloa Pharmaceutical Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥844.46 Million | CN¥1.23 Billion | CN¥386.21 Million | ▲ +10.9% |
| 2024 | 0.62x | CN¥748.01 Million | CN¥1.21 Billion | CN¥460.75 Million | ▲ +59.2% |
| 2023 | 0.39x | CN¥400.90 Million | CN¥1.03 Billion | CN¥630.47 Million | ▼ -36.9% |
| 2022 | 0.62x | CN¥817.00 Million | CN¥1.33 Billion | CN¥509.11 Million | ▲ +518.0% |
| 2021 | -0.15x | CN¥-90.18 Million | CN¥611.75 Million | CN¥701.92 Million | ▼ -121.0% |
| 2020 | 0.70x | CN¥742.41 Million | CN¥1.06 Billion | CN¥317.12 Million | ▼ -28.2% |
| 2019 | 0.98x | CN¥1.33 Billion | CN¥1.36 Billion | CN¥31.85 Million | ▲ +8.3% |
| 2018 | 0.90x | CN¥751.07 Million | CN¥832.69 Million | CN¥81.62 Million | ▲ +308.0% |
| 2017 | 0.22x | CN¥46.38 Million | CN¥209.80 Million | CN¥163.42 Million | ▲ +126.4% |
| 2016 | -0.84x | CN¥-150.93 Million | CN¥180.42 Million | CN¥331.35 Million | ▼ -3285.0% |
| 2015 | -0.02x | CN¥-10.90 Million | CN¥441.16 Million | CN¥452.06 Million | ▼ -107.9% |
| 2014 | 0.31x | CN¥246.42 Million | CN¥786.64 Million | CN¥540.22 Million | ▲ +119.0% |
| 2013 | -1.65x | CN¥-314.56 Million | CN¥190.45 Million | CN¥505.01 Million | ▼ -14928.1% |
| 2012 | -0.01x | CN¥-3.69 Million | CN¥335.90 Million | CN¥339.59 Million | ▲ +95.9% |
| 2011 | -0.27x | CN¥-107.47 Million | CN¥404.62 Million | CN¥289.21 Million | ▼ -71.4% |
| 2010 | -0.15x | CN¥-18.76 Million | CN¥121.05 Million | CN¥139.81 Million | ▼ -128.2% |
| 2009 | 0.55x | CN¥114.64 Million | CN¥208.30 Million | CN¥93.66 Million | ▲ +120.5% |
| 2008 | -2.69x | CN¥-254.47 Million | CN¥94.57 Million | CN¥349.04 Million | ▼ -901.3% |
| 2007 | 0.34x | CN¥58.50 Million | CN¥174.20 Million | CN¥115.70 Million | ▼ -49.3% |
| 2006 | 0.66x | CN¥105.58 Million | CN¥159.43 Million | CN¥53.84 Million | ▲ +269.0% |
| 2005 | -0.39x | CN¥-34.26 Million | CN¥87.40 Million | CN¥121.65 Million | ▲ +70.7% |
| 2004 | -1.34x | CN¥-63.52 Million | CN¥47.54 Million | CN¥111.07 Million | ▼ -915.2% |
| 2003 | 0.16x | CN¥17.27 Million | CN¥105.36 Million | CN¥88.09 Million | ▲ +101.0% |
| 2002 | -15.78x | CN¥-44.42 Million | CN¥2.81 Million | CN¥47.23 Million | ▼ -2991.4% |
| 2000 | 0.55x | CN¥3.86 Million | CN¥7.08 Million | CN¥3.22 Million | ▲ +20.2% |
| 1998 | 0.45x | CN¥13.66 Million | CN¥30.10 Million | CN¥16.43 Million | — |